Efficacy of gut-brain neuromodulators and brain-gut behaviour therapies for irritable bowel syndrome: systematic review and network meta-analysis

肠易激综合征 医学 三环 替加色罗 随机对照试验 临床试验 内科学 再摄取抑制剂 腹痛 疾病 梅德林 抗抑郁药 三环类抗抑郁药 5-羟色胺再摄取抑制剂 认知 药物治疗 血清素 功能性胃肠病 认知行为疗法 精神科 相对风险
作者
Mais Khasawneh,Elyse R. Thakur,Vivek Chand Goodoory,P Moayyedi,Christopher J. Black,Alexander Charles Ford
出处
期刊:Gut [BMJ]
卷期号:: gutjnl-2026 被引量:5
标识
DOI:10.1136/gutjnl-2026-339311
摘要

BACKGROUND: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction, with some recommended treatments targeting brain-gut axis dysfunction. OBJECTIVE: To compare relative efficacy of gut-brain neuromodulators and brain-gut behaviour therapies in IBS. DESIGN: Network meta-analysis searching the medical literature to 8 February 2026 for randomised controlled trials (RCTs) of gut-brain neuromodulators or brain-gut behaviour therapies in adults with IBS. In our main analysis, we judged efficacy using dichotomous endpoints of improvement in either global IBS symptoms or abdominal pain. We pooled data with a random effects model, with efficacy reported as a pooled relative risk (RR) with 95% CIs. We ranked treatments according to P-score; the mean extent of certainty that one treatment is better than another averaged over all competing treatments. RESULTS: We identified 68 eligible RCTs (6694 participants). Compared with waiting list control, in 66 trials (6542 patients), serotonin and norepinephrine reuptake inhibitors (SNRIs) ranked first in six trials (387 patients) (RR of global IBS symptoms or abdominal pain not improving=0.49; 95% CI 0.32 to 0.75, P-score 0.95), meaning the probability that this was the most efficacious treatment was 95%. However, no trials were at low risk of bias. Tricyclic antidepressants (TCAs) ranked second in 15 trials (1519 patients) (RR=0.60; 95% CI 0.43 to 0.85, P-score 0.79) and forms of dynamic psychotherapy/emotional processing third (RR=0.62; 95% CI 0.44 to 0.87, P-score 0.75). Forms of cognitive behavioural therapy (CBT), forms of disease self-management, selective serotonin reuptake inhibitors and forms of gut-directed hypnotherapy (GDH) were also superior to waiting list control. CONCLUSION: Several gut-brain neuromodulators, especially TCAs, and brain-gut behaviour therapies, particularly forms of dynamic psychotherapy/emotional processing, CBT, disease self-management and GDH, are efficacious for IBS. However, there was possible publication bias in some analyses, and overall certainty in the evidence was low or very low for most comparisons.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
花样年华发布了新的文献求助30
1秒前
淡淡的仇天完成签到,获得积分20
1秒前
1234567发布了新的文献求助10
1秒前
何大爷发布了新的文献求助10
1秒前
科研通AI6.3的应助被chi采纳,获得10
1秒前
FashionBoy的应助被李奔采纳,获得10
1秒前
NexusExplorer的应助被Jay采纳,获得10
1秒前
2秒前
歪歪扣叉完成签到,获得积分10
3秒前
年轻觅山发布了新的文献求助10
3秒前
英俊的铭的应助被corleeang采纳,获得10
3秒前
天外来物发布了新的文献求助10
3秒前
YOKIII发布了新的文献求助10
3秒前
科研通AI6.4的应助被旺仔仔采纳,获得10
4秒前
4秒前
5秒前
5秒前
aaaaa完成签到,获得积分10
5秒前
mali123发布了新的文献求助10
6秒前
6秒前
special完成签到,获得积分20
6秒前
林木木完成签到,获得积分20
6秒前
Yogita完成签到,获得积分10
6秒前
7秒前
serenananana完成签到,获得积分20
7秒前
7秒前
7秒前
8秒前
mzt完成签到,获得积分10
8秒前
9秒前
9秒前
9秒前
FashionBoy的应助被corleeang采纳,获得10
10秒前
10秒前
10秒前
xs完成签到 ,获得积分10
10秒前
11秒前
情怀的应助被科研通管家采纳,获得10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124